Stereochemistry of an Agonist Determines Coupling Preference of β2-Adrenoceptor to Different G Proteins in Cardiomyocytes

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Pharmacology

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.108.051078PMID 18838481PMCID PMC2654765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Molecular Field Analysis

  2011cited by this paper
• Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction

  2008cited by this paper
• Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.

  2007cited by this paper
• Dosage‐dependent switch from G protein‐coupled to G protein‐independent signaling by a GPCR

  2007cited by this paper
• Achieving signalling selectivity of ligands for the corticotropin‐releasing factor type 1 receptor by modifying the agonist's signalling domain

  2007cited by this paper
• Structure and Conformational Changes in the C-terminal Domain of the β2-Adrenoceptor

  2007cited by this paper
• Beta-arrestin-biased ligands at seven-transmembrane receptors.

  2007cited by this paper
• Functional Selectivity and Classical Concepts of Quantitative Pharmacology

  2007cited by this paper
• β-Arrestin-biased ligands at seven-transmembrane receptors

  2007cited by this paper
• Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.

  2007cited by this paper
• GPCR functional selectivity has therapeutic impact.

  2007cited by this paper
• Conformational complexity of G-protein-coupled receptors.

  2007cited by this paper
• Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.

  2006influential reference
• Differential phosphorylation and dephosphorylation of β2‐adrenoceptor sites Ser262 and Ser355,356

  2006cited by this paper
• beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.

  2006cited by this paper
• β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor*

  2006cited by this paper
• Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.

  2005cited by this paper
• Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.

  2005cited by this paper
• The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly.

  2005cited by this paper
• The Enigma of β2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly

  2005cited by this paper
• Crosstalk of &bgr;-Adrenergic Receptor Subtypes Through Gi Blunts &bgr;-Adrenergic Stimulation of L-Type Ca2+ Channels in Canine Heart Failure

  2005cited by this paper
• Pharmacological Stimulation of β 2-adrenergic Receptors (β 2AR) Enhances Therapeutic Effectiveness of β 1AR Blockade in Rodent Dilated Ischemic Cardiomyopathy

  2005cited by this paper
• Principles: receptor theory in pharmacology.

  2004cited by this paper
• Loss of β-adrenoceptor response in myocytes overexpressing the Na+/Ca2+-exchanger

  2004cited by this paper
• Beneficial Effects of Chronic Pharmacological Manipulation of &bgr;-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy

  2004cited by this paper
• Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist‐specific G protein activation

  2004cited by this paper
• Na+/Ca2+ exchange linking beta2-adrenergic G(i) signaling to heart failure: associated defect of adrenergic contractile support.

  2004cited by this paper
• Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.

  2004cited by this paper
• Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.

  2004cited by this paper
• Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger.

  2004cited by this paper
• Na+/Ca2+ exchange linking beta2-adrenergic G(i) signaling to heart failure: associated defect of adrenergic contractile support.

  2004cited by this paper
• Effect in Myocytes From Failing Rat Hearts

  2003influential reference
• Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

  2003cited by this paper
• Functional coupling of the human dopamine D2 receptor with Gαi1, Gαi2, Gαi3 and Gαo G proteins: evidence for agonist regulation of G protein selectivity

  2003cited by this paper
• Enhanced Gi Signaling Selectively Negates &bgr;2-Adrenergic Receptor (AR)– but Not &bgr;1-AR–Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts

  2003cited by this paper
• β2-Adrenergic Receptor Lacking the Cyclic AMP-Dependent Protein Kinase Consensus Sites Fully Activates Extracellular Signal-Regulated Kinase 1/2 in Human Embryonic Kidney 293 Cells: Lack of Evidence for Gs/Gi Switching.

  2002cited by this paper
• Beta(2)-adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for G(s)/G(i) switching.

  2002cited by this paper
• Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor*

  2001cited by this paper
• Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.

  2001cited by this paper
• Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction

  2001cited by this paper
• Gq/11 and Gi/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor‐subtype

  2001cited by this paper
• β2-Adrenergic Receptor Activates Extracellular Signal-regulated Kinases (ERKs) via the Small G Protein Rap1 and the Serine/Threonine Kinase B-Raf*

  2000cited by this paper
• Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.

  1999influential reference
• Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

  1997cited by this paper
• Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A

  1997influential reference
• Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.

  1995influential reference
• Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.

  1995cited by this paper
• Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure.

  1994cited by this paper
• Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

  1993cited by this paper
• Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

  1988cited by this paper
• β1‐ and β2‐Adrenergic‐Receptor Subpopulations in Nonfailing and Failing Human Ventricular Myocardium: Coupling of Both Receptor Subtypes to Muscle Contraction and Selective β1‐Receptor Down‐Regulation in Heart Failure

  1986cited by this paper
• Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

  1986cited by this paper

• Therapeutic exploration of biased ligands at class A G protein-coupled receptors over the past 20 years.

  2025cites this paper
• CMV-encoded GPCRs in infection, disease, and pathogenesis.

  2024cites this paper
• Unraveling the Structural Basis of Biased Agonism in the β2‐Adrenergic Receptor Through Molecular Dynamics Simulations

  2024cites this paper
• Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist

  2022cites this paper
• Computational and experimental approaches to probe GPCR activation and signaling.

  2022cites this paper
• RETRACTED ARTICLE: β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma

  2020cites this paper
• Discovery of β-arrestin-biased β2-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives

  2019cites this paper
• Higenamine, a Dual Agonist for β 1- and β 2-Adrenergic Receptors Identified by Screening a Traditional Chinese Medicine Library

  2019cites this paper
• &bgr;2-Adrenergic Stimulation Compartmentalizes &bgr;1 Signaling Into Nanoscale Local Domains by Targeting the C-Terminus of &bgr;1-Adrenoceptors

  2019cites this paper
• Mechanistic Insights into Specific G Protein Interactions with Adenosine Receptors Revealed by Accelerated Molecular Simulations

  2019cites this paper
• Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.

  2019cites this paper
• US28: HCMV’s Swiss Army Knife

  2018cites this paper
• Investigating and exploiting the latency-associated expression of the human cytomegalovirus gene US28 in early myeloid lineage cells.

  2017cites this paper
• Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening

  2017cites this paper
• Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

  2017cites this paper
• Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol

  2017cites this paper
• Stereoselective binding of agonists to the β2-adrenergic receptor: insights into molecular details and thermodynamics from molecular dynamics simulations.

  2017cites this paper
• Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology

  2017influential citation
• Investigating adrenoceptor regulation of the astroglial glycogen reserve

  2017cites this paper
• G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation

  2016cites this paper
• R- and S-terbutaline activate large conductance and Ca2+ dependent K+ (BKCa) channel through interacting with β2 and M receptor respectively.

  2016cites this paper
• Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.

  2016cites this paper
• REVIEW Biased β 2 -adrenoceptor signalling in heart failure: pathophysiology and drug discovery

  2015cites this paper
• Biased β2‐adrenoceptor signalling in heart failure: pathophysiology and drug discovery

  2015cites this paper
• [Contemporary concepts in studies on cyclic AMP and its role in the inflammatory reaction].

  2015cites this paper
• Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2‐adrenoceptor

  2015cites this paper
• Interaction of fenoterol stereoisomers with β2-adrenoceptor-Gsα fusion proteins: antagonist and agonist competition binding

  2015cites this paper
• Three structurally similar odorants trigger distinct signaling pathways in a mouse olfactory neuron.

  2014influential citation
• Emerging structural insights into biased GPCR signaling.

  2014cites this paper
• Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?

  2014cites this paper
• Ligand-directed trafficking of receptor stimulus

  2014cites this paper
• Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor

  2014cites this paper
• Tyrosine 308 Is Necessary for Ligand-directed Gs Protein-biased Signaling of β2-Adrenoceptor*

  2014cites this paper
• Gi Proteins Regulate Adenylyl Cyclase Activity Independent of Receptor Activation

  2014cites this paper
• Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.

  2014cites this paper
• β2-Adrenoceptor-mediated regulation of glucose uptake in skeletal muscle—ligand-directed signalling or a reflection of system complexity?

  2013cites this paper
• Dissociations in the Effects of β2-Adrenergic Receptor Agonists on cAMP Formation and Superoxide Production in Human Neutrophils: Support for the Concept of Functional Selectivity

  2013cites this paper
• β-adrenergic signalling and novel effects in skeletal muscle

  2013cites this paper
• The complexity of G-protein coupled receptor-ligand interactions

  2013cites this paper
• Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?

  2013cites this paper
• Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells.

  2013influential citation
• Novel insights into biased agonism at G protein-coupled receptors and their potential for drug design.

  2013cites this paper
• Struktur und Funktion β-adrenerger Rezeptoren Structure and function of β-adrenergic receptors

  2013cites this paper
• Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery.

  2013cites this paper
• Arrestins in the cardiovascular system.

  2013cites this paper
• Regulation of G protein subunit composition in cardiomyocytes: pharmacological implications

  2013cites this paper
• Cannabinoid Receptor Activation Correlates with the Proapoptotic Action of the β2-Adrenergic Agonist (R,R′)-4-Methoxy-1-Naphthylfenoterol in HepG2 Hepatocarcinoma Cells

  2012cites this paper
• Fenoterol Enantiomers Do Not Possess Beneficial Therapeutic Properties of Their Racemic Mixture in the Rat Model of Post Myocardial Infarction Dilated Cardiomyopathy

  2012influential citation
• Caveolae compartmentalise β2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte

  2012cites this paper
• β-Adrenergic receptor subtype signaling in heart: From bench to bedside

  2012cites this paper
• Unknown Mechanisms Regulating the GPCR Signal Cascade in Vertebrate Photoreceptors

  2012cites this paper
• Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.

  2012cites this paper
• Novel cAMP signalling paradigms: therapeutic implications for airway disease

  2012cites this paper
• Recent progress in understanding of structure, ligand interactions and the mechanism of activation of the β₂-adrenergic receptor.

  2012cites this paper
• Ensemble of G protein-coupled receptor active states.

  2012cites this paper
• JPET # 195206 1 Cannabinoid receptor activation correlates with the pro-apoptotic action of the β 2-adrenergic agonist , ( R , R ’ )-4-methoxy-1-naphthylfenoterol , in HepG 2 hepatocarcinoma cells

  2012cites this paper
• Neuroendocrine GPCR Signaling

  2012cites this paper
• β-adrenergic receptor subtype signaling in the heart: from bench to the bedside.

  2011cites this paper
• β₂ AR agonists in treatment of chronic heart failure: long path to translation.

  2011cites this paper
• β-arrestin-biased signaling by the β-adrenergic receptors.

  2011cites this paper
• Quantification of Functional Selectivity at the Human α1A-Adrenoceptor

  2011cites this paper
• Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.

  2011cites this paper
• Gαs-Biased β2-Adrenergic Receptor Signaling from Restoring Synchronous Contraction in the Failing Heart

  2011cites this paper
• Role of β‐adrenoceptors in glucose uptake in astrocytes using β‐adrenoceptor knockout mice

  2011cites this paper
• MODELLING β2AR REGULATION

  2011cites this paper
• Integrated Synthetic, Pharmacological, and Computational Investigation of cis‐2‐(3,5‐Dichlorophenylcarbamoyl)cyclohexanecarboxylic Acid Enantiomers As Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 4

  2011cites this paper
• Functional characterization of the 5-oxo-ETE receptor OXE-R and identification of the first small molecule antagonist with a novel mechanism of ligand bias

  2011cites this paper
• The Effects of β 2 -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria

  2011cites this paper
• Real time analysis of β2-adrenoceptor-mediated signaling kinetics in Human Primary Airway Smooth Muscle Cells reveals both ligand and dose dependent differences

  2011cites this paper
• Post-translational modifications regulate β2-Adrenoceptor signaling in cardiac myocytes

  2011cites this paper
• Development of pharmacological modulators for the orphan G protein-coupled receptor GPR17 and their application for the investigation of molecular signal transduction pathways

  2011cites this paper
• β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma Cells

  2011influential citation
• Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling.

  2011cites this paper
• The design, synthesis and pharmacological characterization of novel β2‐adrenoceptor antagonists

  2011cites this paper
• Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β2AR

  2011influential citation
• Resolution of controversies in drug/receptor interactions by protein structure. Limitations and pharmacological solutions.

  2011cites this paper
• Pharmacokinetics and metabolism of (R,R)-methoxyfenoterol in rat

  2010influential citation
• Quantitative Modeling of GRK-Mediated β2AR Regulation

  2010cites this paper
• The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.

  2010cites this paper
• No Evidence for Functional Selectivity of Proxyfan at the Human Histamine H3 Receptor Coupled to Defined Gi/Go Protein Heterotrimers

  2010cites this paper
• Pathway-specific, species, and sub-type counterscreening for better GPCR hits in high throughput screening.

  2010cites this paper
• Quantification of functional selectivity at the human α 1A -adrenoceptor

  2010cites this paper
• Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.

  2010cites this paper
• Ligand‐directed signalling at β‐adrenoceptors

  2010influential citation
• Molecular analysis of the histamine H3-receptor

  2010cites this paper
• Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

  2010cites this paper
• The year in G protein-coupled receptor research.

  2010cites this paper
• Human Cytomegalovirus US28: a functionally selective chemokine binding receptor.

  2009cites this paper
• Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities

  2009influential citation
• Synthesis of Tritium Labeled (R,R)-4-Methoxyfenoterol.

  2009cites this paper
• Cancer Management and Research Dovepress Critical Appraisal of the Potential Use of Cannabinoids in Cancer Management

  year unknowncites this paper